Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins http://pennlab.ca/wp-content/uploads/2023/05/Screen-Shot-2023-05-18-at-12.24.29-PM.png 757 671 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2023/05/Screen-Shot-2023-05-18-at-12.24.29-PM.png May 18, 2023 May 18, 2023 May 18, 2023 0 read more
The MYC oncoprotein directly interacts with its chromatin cofactor PNUTS to recruit PP1 phosphatase http://pennlab.ca/wp-content/uploads/2022/03/m_gkac138figgra1.jpeg 520 391 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2022/03/m_gkac138figgra1.jpeg March 28, 2022 March 28, 2022 March 28, 2022 0 read more
MYC protein interactors in gene transcription and cancer http://pennlab.ca/wp-content/uploads/2021/07/Lourenco_MYC_review.png 605 482 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2021/07/Lourenco_MYC_review.png July 11, 2021 March 28, 2022 July 11, 2021 0 read more
Identifying and Validating MYC:Protein Interactors in Pursuit of Novel Anti-MYC Therapies http://pennlab.ca/wp-content/uploads/2023/05/MYC-Interactor-Identification-Pipeline-854x1024.webp 854 1024 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2023/05/MYC-Interactor-Identification-Pipeline-854x1024.webp May 25, 2021 May 18, 2023 May 25, 2021 0 read more
Mevalonate pathway inhibition slows breast cancer metastasis via reduced N-glycosylation abundance and branching http://pennlab.ca/wp-content/uploads/2021/02/Rosemary_Dolichol.png 396 361 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2021/02/Rosemary_Dolichol.png February 21, 2021 February 21, 2021 February 21, 2021 0 read more
Statins as Anticancer Agents in the Era of Precision Medicine http://pennlab.ca/wp-content/uploads/2020/11/Screen-Shot-2020-11-05-at-12.14.41-PM.png 717 688 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/11/Screen-Shot-2020-11-05-at-12.14.41-PM.png November 5, 2020 November 5, 2020 November 5, 2020 0 read more
Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death http://pennlab.ca/wp-content/uploads/2020/08/JL_cAMP-paper.png 952 562 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/08/JL_cAMP-paper.png August 26, 2020 August 26, 2020 August 26, 2020 0 read more
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma http://pennlab.ca/wp-content/uploads/2020/07/JL_t414-paper_cropped.png 295 211 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/07/JL_t414-paper_cropped.png July 14, 2020 July 14, 2020 July 14, 2020 0 read more
A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer http://pennlab.ca/wp-content/uploads/2020/03/JL_WinSTOP-trial_square-1024x796.png 1024 796 Penn Lab Penn Lab http://pennlab.ca/wp-content/uploads/2020/03/JL_WinSTOP-trial_square-1024x796.png March 19, 2020 March 19, 2020 March 19, 2020 0 read more